Publication Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Koval A V, Vlasov P, Shichkova P, et al. Biochemical pharmacology. 2014; 87 (4) : 571-8.
Publication Anti-leprosy drug Clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Koval A V, Vlasov P, Shichkova P, et al. Biochemical pharmacology. 2013;
Publication Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes. Anderson R, Beyers A D, Savage J E, et al. Biochemical pharmacology. 1988; 37 (24) : 4635-41.